## Abstract ## BACKGROUND The current systematic review and metaβanalysis compared monotherapy and combined androgen blockade in the treatment of men with advanced prostate carcinoma. Outcomes of interest included overall, cancer specific, and progressionβfree survival; time to treatment failure;
Combined androgen blockade for advanced prostatic carcinoma
β Scribed by Goktas, S; Ziada, A; Crawford, E D
- Book ID
- 110073131
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 339 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1365-7852
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The current issue of __Cancer__ includes a report on a concise, randomized controlled trial (RCT) with longβterm followβup that favors combined androgen blockade with bicalutamide versus lutenizing hormoneβreleasing hormone monotherapy in Japanese men with locally advanced and metastatic prostate ca
Despite a number of large randomized clinical trials, there still is uncertainty regarding the value of maximal androgen blockade in the treatment of patients with advanced prostate carcinoma. In the referenced article, the authors provide a very comprehensive review of the literature concerning one